Thema Nicholson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Thema Nicholson has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Surena Namdari
Rothman Orthopaedic Institute
10 shared publications Benjamin Zmistowski
3 shared publicationsGerald R. Williams
3 shared publicationsJoseph A. Abboud
3 shared publicationsMark D. Lazarus
3 shared publicationsAdam Watts
2 shared publications
Latest Publications
- 17 November 2022
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 33 (2) , 240-245
The utilization of platelet parameters as an adjunct indicator for the diagnosis of shoulder periprosthetic joint infection
- 17 November 2022
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 33 (2) , 240-245
The utilization of platelet parameters as an adjunct indicator for the diagnosis of shoulder periprosthetic joint infection
- 28 October 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (4) , e168-e174
An enhanced understanding of shoulder periprosthetic joint infection using next-generation sequencing: findings at the 3-year clinical follow-up
- 28 October 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (4) , e168-e174
An enhanced understanding of shoulder periprosthetic joint infection using next-generation sequencing: findings at the 3-year clinical follow-up
- 12 August 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (11) , 2211-2216
The effect of tranexamic acid for visualization on pump pressure and visualization during arthroscopic rotator cuff repair: an anonymized, randomized controlled trial
- 12 August 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (11) , 2211-2216
The effect of tranexamic acid for visualization on pump pressure and visualization during arthroscopic rotator cuff repair: an anonymized, randomized controlled trial
- 1 October 2021
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 30 (10) , 2331-2335
Outcomes of open reduction and internal fixation of proximal humerus fracture dislocations
- 1 October 2021
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 30 (10) , 2331-2335
Outcomes of open reduction and internal fixation of proximal humerus fracture dislocations
- 1 September 2020
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 29 (9) , 1831-1835
Clinically significant subscapularis failure after anatomic shoulder arthroplasty: is it worth repairing?
- 1 September 2020
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 29 (9) , 1831-1835
Clinically significant subscapularis failure after anatomic shoulder arthroplasty: is it worth repairing?
- 1 March 2020
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 29 (3) , 550-560
Early radiographic failure of reverse total shoulder arthroplasty with structural bone graft for glenoid bone loss
- 1 March 2020
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 29 (3) , 550-560
Early radiographic failure of reverse total shoulder arthroplasty with structural bone graft for glenoid bone loss
- 1 January 2019
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 9 (3) , e0161
Rotational Osteotomy of the Humeral Shaft for Malunion in Osteogenesis Imperfecta
Case: We report a case of an adult with osteogenesis imperfecta, who underwent humeral shaft osteotomy to correct an internal rotation deformity results from a humeral shaft malunion. The patient incurred a temporary radial nerve palsy. Conclusions: Humeral shaft malunion can be successfully treated with rotational osteotomy of the humerus through an anterior approach; however, the risk of radial nerve palsy exists and may be minimized by a posterior approach.
- 1 January 2019
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 9 (3) , e0161
Rotational Osteotomy of the Humeral Shaft for Malunion in Osteogenesis Imperfecta
Case: We report a case of an adult with osteogenesis imperfecta, who underwent humeral shaft osteotomy to correct an internal rotation deformity results from a humeral shaft malunion. The patient incurred a temporary radial nerve palsy. Conclusions: Humeral shaft malunion can be successfully treated with rotational osteotomy of the humerus through an anterior approach; however, the risk of radial nerve palsy exists and may be minimized by a posterior approach.
- 15 August 2018
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 100 (16) , 1373-1378
Interscalene Block with and without Intraoperative Local Infiltration with Liposomal Bupivacaine in Shoulder Arthroplasty
Background: Interscalene brachial plexus blockade (ISBPB) is an effective anesthetic technique for shoulder arthroplasty; however, “rebound pain” can increase the patient’s postoperative pain experience and narcotic usage. Exparel (liposomal bupivacaine) injected into the soft tissues at the surgical site has theoretical efficacy for up to 72 hours after administration. The purpose of this study was to evaluate postoperative pain scores and narcotic consumption following shoulder arthroplasty performed with either ISBPB alone or ISBPB and intraoperative Exparel. Methods: Seventy-eight patients undergoing primary shoulder arthroplasty were randomized to receive an ISBPB with Exparel (39 patients) or without Exparel (39 patients). The primary outcome variable was morphine equivalent units (MEUs) consumed over the first 24 hours after surgery. Secondary outcomes included intraoperative narcotic administration and visual analog scale (VAS) scores for pain (at 0, 8, 16, 24, 48, and 72 hours after surgery). Results: There were no significant demographic differences between the ISBPB and ISBPB + Exparel groups. Total narcotic consumption over the first 24 hours after surgery was significantly lower in the ISBPB group compared with the ISBPB + Exparel group (mean and standard deviation, 18.9 ± 25.6 MEU versus 35.3 ± 36.7 MEU, p = 0.009). VAS pain scores did not differ significantly between groups at any time point during the first 72 hours after surgery. Conclusions: Patients treated with Exparel required significantly more postoperative narcotics and demonstrated no significant reduction in pain scores over the first 72 hours after primary shoulder arthroplasty. Exparel does not appear to have substantial value when added to a pain protocol that includes an ISBPB. Level of Evidence: Therapeutic Level l. See Instructions for Authors for a complete description of levels of evidence.
- 15 August 2018
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 100 (16) , 1373-1378
Interscalene Block with and without Intraoperative Local Infiltration with Liposomal Bupivacaine in Shoulder Arthroplasty
Background: Interscalene brachial plexus blockade (ISBPB) is an effective anesthetic technique for shoulder arthroplasty; however, “rebound pain” can increase the patient’s postoperative pain experience and narcotic usage. Exparel (liposomal bupivacaine) injected into the soft tissues at the surgical site has theoretical efficacy for up to 72 hours after administration. The purpose of this study was to evaluate postoperative pain scores and narcotic consumption following shoulder arthroplasty performed with either ISBPB alone or ISBPB and intraoperative Exparel. Methods: Seventy-eight patients undergoing primary shoulder arthroplasty were randomized to receive an ISBPB with Exparel (39 patients) or without Exparel (39 patients). The primary outcome variable was morphine equivalent units (MEUs) consumed over the first 24 hours after surgery. Secondary outcomes included intraoperative narcotic administration and visual analog scale (VAS) scores for pain (at 0, 8, 16, 24, 48, and 72 hours after surgery). Results: There were no significant demographic differences between the ISBPB and ISBPB + Exparel groups. Total narcotic consumption over the first 24 hours after surgery was significantly lower in the ISBPB group compared with the ISBPB + Exparel group (mean and standard deviation, 18.9 ± 25.6 MEU versus 35.3 ± 36.7 MEU, p = 0.009). VAS pain scores did not differ significantly between groups at any time point during the first 72 hours after surgery. Conclusions: Patients treated with Exparel required significantly more postoperative narcotics and demonstrated no significant reduction in pain scores over the first 72 hours after primary shoulder arthroplasty. Exparel does not appear to have substantial value when added to a pain protocol that includes an ISBPB. Level of Evidence: Therapeutic Level l. See Instructions for Authors for a complete description of levels of evidence.